Total Funding
75
62
Total FundingSeries A raised
Growth Score 75 in past quarter
-9 pts
Heat Score 62 in past quarter
-25 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
26772
Inimmune is focused on the discovery and development of novel immunotherapeutics for an array of disease areas.
- David Burkhart: Co-Founder
- Helene Bazin-Lee: Co-Founder & Vice President Early Discovery
About the Company
Inimmune is focused on the discovery and development of novel immunotherapeutics for an array of disease areas.
Inimmune technology is focused on the discovery, optimization, and development of new innate immune receptor agonists and antagonists to treat a wide array of medical conditions including allergy, autoimmune diseases, and cancer.
It was
founded in 2016 and based in Missoula, Montana.
Women Founded